Article
Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery.
Clinical lung cancer - 1 Mar 2017
Santarpia Mariacarmela, Ramirez Jose Luis, de Aguirre Itziar, Garrido Pilar, Pérez Cano Maria, Queralt Cristina, Gonzalez-Larriba Jose Luis, Insa Amelia, Provencio Mariano, Isla Dolores, Camps Carlos, Blanco Remei, Moran Teresa, Rosell Rafael
Abstract excerpt
OBJECTIVE: The aim of this study was to evaluate whether xeroderma pigmentosum group D (XPD) and ribonucleotide reductase subunit M1 (RRM1) polymorphisms influenced clinical outcome in patients with stage IIIA-B non-small-cell lung cancer (NSCLC) treated with neoadjuvant gemcitabine/cisplatin/docetaxel followed by surgery. MATERIALS AND METHODS: A total of 109 patients with stage IIIA and IIIB NSCLC were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
